Does Polycythemia Cause Hyperuricemia?
Yes, polycythemia directly causes hyperuricemia through increased red blood cell turnover and altered renal handling of uric acid, with the severity of hyperuricemia correlating with the degree of erythrocytosis.
Mechanism and Evidence
The relationship between polycythemia and hyperuricemia is well-established through multiple pathophysiologic mechanisms:
Primary Mechanism: Increased Cell Turnover
Increased breakdown of red blood cells in chronic polycythemia results in elevated purine catabolism, leading to hyperuricemia 1. This is particularly evident in cyanotic congenital heart disease, where the degree of hyperuricemia correlates directly with the severity of polycythemia (r = 0.44; P < 0.02) 2. In high-altitude polycythemia with excessive erythrocytosis (hematocrit >65%), serum urate levels show an even stronger correlation with hematocrit (r = 0.71; P < 0.0001) 3.
Secondary Mechanism: Impaired Renal Excretion
Abnormal urate clearance compounds the problem 1. In patients with excessive erythrocytosis at high altitude, urate production is increased (demonstrated by elevated 24-hour urine urate excretion), but fractional urate excretion is not proportionally increased 3. This suggests that while urate generation increases due to systemic hypoxia, the kidneys fail to compensate adequately, with evidence of increased proximal tubular reabsorption of both sodium and urate 3.
Clinical Significance by Type
Polycythemia Vera (PV)
In PV, hyperuricemia occurs as part of the myeloproliferative process 4, 5. The clonal proliferation of all myeloid lineages increases cell turnover beyond just erythrocytes, amplifying uric acid production.
Secondary Polycythemia
- Cyanotic congenital heart disease: 81% of cyanotic male patients over 15 years old have serum uric acid >8 mg/dL 2
- High-altitude polycythemia: Hyperuricemia is common and associated with exposure duration (OR 6.744 for 1-5 years exposure) and the presence of high-altitude polycythemia itself (OR 2.125) 6
- Post-renal transplant erythrocytosis: Recognized as a cause of hyperuricemia 7
Clinical Thresholds and Complications
Serum uric acid levels >10 mg/dL are likely nephropathic 2, making monitoring critical even in asymptomatic patients. The hyperuricemia in polycythemia is often accompanied by:
- Hypertension (uric acid correlates with mean blood pressure, r = 0.50; P < 0.0001) 3
- Proteinuria (more prevalent in excessive erythrocytosis groups) 3
- Increased risk of gout (though clinically symptomatic gout remains relatively uncommon) 1, 3
Management Approach
When to Treat
Hyperuricemia without gout is usually well tolerated and rarely requires intervention 1. However, symptomatic gout should be treated 1, and treatment should be considered when complications arise, including gout, tophi, or uric acid stones 8.
Treatment Considerations
When treatment is necessary:
- Avoid allopurinol if the patient is on azathioprine (contraindicated) 8
- Use colchicine for acute gout with appropriate dose reduction for reduced kidney function and concomitant calcineurin inhibitor use 8
- Avoid NSAIDs and COX-2 inhibitors whenever possible 8
- Address the underlying polycythemia: In PV, phlebotomy to maintain hematocrit <45% is the cornerstone of treatment 5
Important Caveats
The primary focus should be on treating the underlying polycythemia rather than isolated hyperuricemia. In cyanotic heart disease, therapeutic phlebotomy is usually unnecessary unless hemoglobin exceeds 20 g/dL and hematocrit is >65% with hyperviscosity symptoms 1. Repetitive phlebotomies can deplete iron stores, creating iron-deficient red blood cells with reduced oxygen-carrying capacity and increased stroke risk 1.
Key Clinical Pitfalls
- Don't assume all hyperuricemia needs treatment: Asymptomatic hyperuricemia in polycythemia may not warrant urate-lowering therapy unless levels are very high (>10 mg/dL) or complications develop
- Monitor renal function closely: The combination of hyperuricemia, hypertension, and proteinuria can accelerate kidney disease 3
- Consider altitude exposure history: In patients with polycythemia and hyperuricemia, ask about high-altitude exposure, as this significantly increases risk 6